Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Clinical trial NCT02585869 · COMPLETED

Trial details

NCT number: NCT02585869
Sponsor: NeuroBo Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia Hypertriglyceridemia

Start date: 1999-12-01
Primary completion: 2001-06-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.